HSBC Holdings’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$229K Buy
44,326
+30,077
+211% +$155K ﹤0.01% 2148
2025
Q1
$91.1K Sell
14,249
-12,060
-46% -$77.1K ﹤0.01% 2369
2024
Q4
$192K Buy
+26,309
New +$192K ﹤0.01% 2315
2024
Q3
Sell
-46,222
Closed -$405K 2728
2024
Q2
$405K Buy
46,222
+27,605
+148% +$242K ﹤0.01% 1751
2024
Q1
$189K Sell
18,617
-3,109
-14% -$31.5K ﹤0.01% 2300
2023
Q4
$219K Buy
21,726
+5,655
+35% +$56.9K ﹤0.01% 1970
2023
Q3
$151K Buy
+16,071
New +$151K ﹤0.01% 1987
2022
Q4
Sell
-13,776
Closed -$270K 2676
2022
Q3
$270K Sell
13,776
-2,696
-16% -$52.8K ﹤0.01% 2044
2022
Q2
$422K Buy
+16,472
New +$422K ﹤0.01% 2043
2022
Q1
Sell
-8,634
Closed -$362K 2976
2021
Q4
$362K Buy
+8,634
New +$362K ﹤0.01% 2191